Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
07 March 2025 - 9:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number: |
001-39102 |
TFF PHARMACEUTICALS, INC.
Nasdaq Capital Market |
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |
124 Washington Street, Suite 101
Foxborough, MA 02035
((508) 543-1720 |
(Address, including zip code, and telephone number,
including area code, of Issuer’s principal
executive offices) |
|
Common Stock, par value $0.001 per share |
(Description of class of securities) |
|
Please place an X in the box to designate the rule provision relied
upon to strike the class of securities from listing and registration:
| ☐ | Pursuant
to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of
securities from listing and/or withdraw registration on the Exchange. |
| ☒ | Pursuant
to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements
of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from
listing and registration on the Exchange. |
Pursuant to the requirements of the Securities
Exchange Act of 1934, TFF Pharmaceuticals, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
|
TFF PHARMACEUTICALS, INC. |
|
|
|
Date: March 6, 2025 |
By: |
/s/ Craig Jalbert |
|
Name: |
Craig Jalbert |
|
Title: |
Chief Executive Officer |
TFF Pharmaceuticals (NASDAQ:TFFP)
Historical Stock Chart
From Feb 2025 to Mar 2025
TFF Pharmaceuticals (NASDAQ:TFFP)
Historical Stock Chart
From Mar 2024 to Mar 2025